Effect of BIA 9-1067 on Cardiac Repolarization in Healthy Adult Men and Women

NCT01532115 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: BIA 9-1067
DRUG: Placebo
DRUG: moxifloxacin

Sponsor

Bial - Portela C S.A.